DOCSLIB.ORG

Ep 1466621 A1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ep 1466621 A1 Europäisches Patentamt *EP001466621A1* (19) European Patent Office Office européen des brevets (11) EP 1 466 621 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC (43) Date of publication: (51) Int Cl.7: A61K 38/40, A61K 38/16, 13.10.2004 Bulletin 2004/42 A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/48, (21) Application number: 02793463.7 A61P 1/16, A61P 3/04, (22) Date of filing: 27.12.2002 A61P 3/06, A61P 3/10, A61P 9/12 (86) International application number: PCT/JP2002/013858 (87) International publication number: WO 2003/057245 (17.07.2003 Gazette 2003/29) (84) Designated Contracting States: • TAKEUCHI, Takashi AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Tottori-shi, Tottori 680-0945 (JP) IE IT LI LU MC NL PT SE SI SK TR • ANDO, Kunio Designated Extension States: Kawasaki-shi, Kanagawa 213-0033 (JP) AL LT LV MK RO • SHIMIZU, Hirohiko Mishima-shi, Shizuoka 411-0803 (JP) (30) Priority: 28.12.2001 JP 2001400641 (74) Representative: Behnisch, Werner, Dr. et al (71) Applicant: NRL Pharma, Inc. Reinhard-Skuhra-Weise & Partner, Kawasaki-shi, Kanagawa 213-0012 (JP) Patentanwälte, Postfach 44 01 51 (72) Inventors: 80750 München (DE) • HARADA, Etsumori Tottori-shi, Tottori 680-0941 (JP) (54) COMPOSITIONS FOR IMPROVING LIPID METABOLISM (57) The present invention provides a pharmaceuti- cal composition having at least one kind to be selected from the group consisting of a lactoferrin group protein comprising lactoferrin and conalbumin, and an enzy- matically decomposed product of the lactoferrin group protein comprising peptides corresponding to lactofer- ricin and lactoferricin of conalbumin an active ingredient. The composition of the present invention can be used as an agent for improving lipid metabolism. Further, it is useful for treating hypercholesterolemia, hyper-neutral lipidemia, hyper-low density lipoprotein (LDL) choleste- rolemia, hypo-high density lipoprotein (HDL) cholester- olemia, obesity, fatty liver and cholesterol gallstone and lifestyle-related diseases such as severe obesity, hyper- lipidemia, hypertension and type II diabetes. The com- position of the present invention can improve basal met- abolic rate. EP 1 466 621 A1 Printed by Jouve, 75001 PARIS (FR) 1 EP 1 466 621 A1 2 Description lipoprotein (LDL) and conversely decreases the choles- terol concentration present in blood high density lipopro- TECHNICAL FIELD tein (HDL) to trigger arteriosclerosis. Accordingly, the development of drugs or processed foods which can in- [0001] The present invention relates to a pharmaceu- 5 crease blood high density lipoprotein (HDL) cholesterol tical composition comprising lactoferrin and the like. The and conversely can decrease low density lipoprotein composition of the present invention can be used as an (LDL) cholesterol is one of the most globally demanded agent for improving lipid metabolism. More specifically, developments. Since statin drugs such as provastatin, the composition of the present invention is useful for simbastatin and atorvastatin which inhibit hydroxymeth- treating hypercholesterolemia, hyper-neutral lipidemia, 10 ylglutaryl conenzyme A reductase to reduce the synthet- hyper-low density lipoprotein (LDL) cholesterolemia, ic amount of the internal cholesterol play an important hypo-high density lipoprotein (HDL) cholesterolemia, role in treating the diseases of the circulatory system, obesity, fatty liver and cholesterol gallstone, and further the treatment of obesity, that is, lipid metabolic disorder for treating lifestyle-related diseases such as severe is clearly a most urgent problem. obesity, hyperlipidemia, hypertension and type II diabe- 15 [0005] The cause of obesity is overeating. By control- tes. The composition of the present invention can im- ling the appetite and increasing the physical energy con- prove basal metabolic rate. sumption together with therapeutic exercise such as jogging, anyone may well reduce weight theoretically. BACKGROUND ART However, to eat moderately and take exercise of its own 20 volition is not so simple as in words, and even if it is [0002] Our time is an age of plentiful food. With it, possible to eat moderately, reality is not so simple. It is obesity has surfaced as an important health problem said that to change eating habits established in child- which has to be overcome. In the United State of Amer- hood is the most difficult habit among the many. The ap- ica, about 30% of elementary school children are re- petite is one of pleasures which can be easily satisfied. garded as overweight children who exceed the standard 25 Furthermore, on becoming obese, thermal energy is re- weight by 30% or more. As is clear from various epide- duced in consumption and stored as the body fat that miological surveys, the obesity of school age mostly pro- much more, and thus obesity is caught in a vicious circle ceeds after attaining manhood. With it, overweight per- of bringing about obesity. The reduction in weight by sons who exceed the standard weight by 30% or more moderation in eating brings forward a health problem as appear in succession at the aging stage of from the sec- 30 well. The reduction in weight by the reduction in energy ond half of 30 years old to middle age, and thus the total intake not only reduces the white fat tissue whose de- obesity population in Western countries has accounted crease is desired but also reduces the weight of paren- for a large ratio which human beings have never expe- chymal organs at the same rate. The weight reduction rienced. Although not so conspicuous as in Western in parenchymal organs lowers immunological compe- countries, the increase of overweight children due to in- 35 tence, and the body resistance to pathogenic virus and sufficient exercise and satiation has come to a serious pathogenic microorganisms is weakened to be readily problem even in our country. seized with a disease such as a cold. Thus, what is de- [0003] Needless to say, obesity is an important dan- manded in this time of day is a weight reduction method gerous factor to the onset of ischemic heart disease, es- of selectively burning the neutral fat stored in the white sential hypertension, type II diabetes or a certain type 40 fat tissue without accompanying the weight reduction of of cancer, and the age of severe obesity is becoming parenchymal organs. lower and lower to announce a sudden increase of life- [0006] As the drugs which act on the central nerves style-related diseases beforehand. Further, also fatty to cause moderation in eating, the major ones are drugs liver and cholesterol gallstone are diseases with obesity such as madindol [C. Sirtori et al., Am. J. Med. Sci. 261: and lipid metabolic disorder for a background which can- 45 341-7(1971)] which act on the feeding center to reduce not be overlooked. Obesity not only accelerates the on- the appetite or drugs such as a stimulant and an am- set of lifestyle-related diseases but also inactivate ac- phetamine compound [O.J. Kalant, "The Ampheta- tivities to psychologically making adaptability to the so- mines; Toxicity and Addiction" (Thomas, Springfield, cial life difficult. Accordingly, obesity is a large econom- 1966)] which exhibit strong dissimilation and feed glu- ical and social loss. In the countries where overweight 50 cose by decomposition of the body constituents to re- persons are suddenly increasing, the development of duce the appetite. However, madindol has a side effect methods of preventing/treating obesity while maintain- of inducing strong constipation to cause liver disorder. ing physical condition is a pressing need. Further, the amphetamine drugs are habit-forming, and [0004] Above all, drugs or processed foods which can once fallen into drug dependence, it is very difficult to inhibit the absorption of fat in the digestive tract without 55 get out of it, and thus they have not been used as anoret- side effects are essential in the prevention/treatment of ics at all. obesity. The obesity due to overeating increases the [0007] A therapeutic method of shortening the small cholesterol concentration present in blood low density intestine by excision by a surgical operation to reduce 2 3 EP 1 466 621 A1 4 the area of the small intestinal mucosa which relates to a therapeutic drug for reducing the weight of a severely digestion and absorption. However, for improvement of obese person, and it is reported that about 30% of the obesity or hyperlipidemia, excision of part of the sound dietary fat taken in is inhibited from absorption and dis- digestive tract is not the proper way. There is a possibil- charged. However, as the defects, there are frequent di- ity that the danger of a pathogenic infection by the ab- 5 arrhea, abdominal distension and gas generation, and dominal surgical operation or the influence by shorten- furthermore it is reported that hypertension and liver fail- ing of the small intestine will be surfaced as some dis- ure are induced as the systemic side effect. Orlistat ex- ease with ages. plosively came to wide use at the time of release but [0008] Western-type meals are different from meals gradually ceased to be used due to a rash of side effects of the East Asian countries including Japan which use 10 and at present, the amount of use is one third of its ze- carbohydrates as the major energy source. The ratio of nith. When orlistat is used for a long period of time in neutral fat in caloric intake among the Western foods is order to reduce weight, periodical monitoring is required estimated 35% to 43% although it slightly varies in every and orlistat is mainly being used for severely obese per- area. Ideally, the ratio of fat in energy intake is preferably sons under the supervision of a doctor. 30% or less, and furthermore it is recommended that 15 [0011] Drugs or processed foods which reduce the ar- animal fat and butterfat which mostly contain saturated ea on which pancreatic lipase acts by fusing the micelles fatty acids are not more than half of the fat to be taken of dietary fat with each other and inhibit the absorption in and the remainder is taken in as vegetable oil and fish of dietary neutral fat have not been widely put into prac- oil which largely contain unsaturated fatty acids.
Load more

Recommended publications
  • Egg Consumption and Human Health
    nutrients Egg Consumption and Human Health Edited by Maria Luz Fernandez Printed Edition of the Special Issue Published in Nutrients www.mdpi.com/journal/nutrients Egg Consumption and Human Health Special Issue Editor Maria Luz Fernandez MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Maria Luz Fernandez University of Connecticut USA Editorial Office MDPI AG St. Alban-Anlage 66 Basel, Switzerland This edition is a reprint of the Special Issue published online in the open access journal Nutrients (ISSN 2072-6643) in 2015–2016 (available at: http://www.mdpi.com/journal/nutrients/special issues/egg-consumption-human-health). For citation purposes, cite each article independently as indicated on the article page online and as indicated below: Lastname, F.M.; Lastname, F.M. Article title. Journal Name. Year. Article number, page range. First Edition 2018 ISBN 978-3-03842-666-0 (Pbk) ISBN 978-3-03842-667-7 (PDF) Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Table of Contents About the Special Issue Editor ...................................... v Preface to ”Egg Consumption and Human Health” .......................... vii Jose M. Miranda, Xaquin Anton, Celia Redondo-Valbuena, Paula Roca-Saavedra, Jose A.
    [Show full text]
  • Tangential Flow Filtration of Haptoglobin
    Received: 10 January 2020 Revised: 7 April 2020 Accepted: 21 April 2020 DOI: 10.1002/btpr.3010 RESEARCH ARTICLE Tangential flow filtration of haptoglobin Ivan S. Pires | Andre F. Palmer William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State Abstract University, Columbus, Ohio Haptoglobin (Hp) is a plasma glycoprotein that scavenges cell-free hemoglobin (Hb). Correspondence Hp has various potential therapeutic applications, but it has been mainly studied for *Andre F. Palmer, William G. Lowrie treatment of acute hemolytic conditions that can arise from situations such as mas- Department of Chemical and Biomolecular Engineering, The Ohio State University, sive blood transfusion, infusion of stored red blood cells, severe burns, trauma, sepsis, 151 West Woodruff Ave, Columbus, OH radiation injury, and others. Therefore, Hp may also be beneficial during chronic 43210. Email: [email protected] hemolytic disease states such as hereditary spherocytosis, nocturnal hemoglobinuria, sickle-cell anemia, and malaria. Various methods have been developed to purify Hp Funding information National Cancer Institute, Grant/Award from plasma or plasma fractions. However, none of these methods have exploited Number: P30 CA016058; National Heart, the large molecular weight (MW) range distribution of Hp polymers to easily isolate Lung, and Blood Institute, Grant/Award Numbers: R01HL126945, R01HL138116, Hp from other plasma proteins. The present study used tangential flow filtration R56HL123015; National Institute of (TFF) to isolate polymeric Hp from plasma proteins using human Fraction IV (FIV) as Biomedical Imaging and Bioengineering, Grant/ Award Number: R01EB021926; NIH Office of the starting material. After removal of insoluble material from a suspension of FIV the Director, Grant/Award Number: S10 paste, the protein mixture was clarified on a 0.2 μm hollow fiber (HF) TFF filter.
    [Show full text]
  • Life Technologies (India) Pvt. Ltd. 306, Aggarwal City Mall, Opposite M2K Pitampura, Delhi – 110034 (INDIA)
    Product Specification Sheet Chicken conalbumin (ovotransferrin) proteins Antibodies Cat # CECA15-S Rabbit Anti-Chicken conalbumin protein antiserum SIZE: 100 ul Cat # CECA15-C Chicken conalbumin protein control for Western blot SIZE: 100 ul Cat # CECA16-N Chicken conalbumin proteins SIZE: 10 mg liquid at 10 mg/ml in PBS 0.05% azide or in powder form. Allergy to chicken egg or proteins is one of the more frequent Reconstitute powder in PBS at 1-10 mg/ml. It can be used causes of food hypersensitivity in infants and young children. Both positive control for antibody #CECA15-S or for coating IgG and IgA class antibodies may be detected. Ovalbumin ELISA plates. intolerance has been implicated in a number of conditions affecting children. In particular, children with cystic fibrosis show elevated anti-ovalbumin antibodies. Ovalbumin antibodies have For Western blot +ve control (Cat # CECA15-C) is supplied also been noted in some forms of kidney disease. A relationship in SDS-PAGE sample buffer (reduced). Load 10 ul/lane of between food allergy and infantile autism has also been observed. #CECA15-C for good visibility with antibody Cat #CECA15- Children with insulin-dependent diabetes mellitus show an S. Store at –20oC in suitable size aliquots. SDS may enhanced immune response to both β-lactoglobulin and crystallize in cold conditions. It should redissolve by ovalbumin, a phenomenon that may be related to the development warming before taking it from the stock. It should be of the disease. Conditions related to ovalbumin intolerance usually heated once prior to loading on gels. If the product has resolve once egg and egg based foods have been withdrawn from been stored for several weeks, then it may be preferable to the patient's diet.
    [Show full text]
  • Conalbumin More Resistant to Proteolysis and Ther- the Use Of
    IRON AND PROTEIN KINETICS STUDIED BY MEANS OF DOUBLY LABELED HUMAN CRYSTALLINE TRANSFERRIN * BY JAY H. KATZ (From the Radioisotope and Medical Services of the Boston Veterans Administration Hospital, and the Dept. of Medicine, Boston University School of Medicine, Boston, Mass.) (Submitted for publication June 16, 1961; accepted August 10, 1961) Although proteins isotopically labeled with io- demonstrated that not only is the iron complex of dine have been used in tracer studies for some conalbumin more resistant to proteolysis and ther- years, interest has been mainly focused on their mal denaturation than the metal-free protein, but distribution and degradation in the body. While it that it is possible to maintain the iron-binding ca- is often possible to produce iodoproteins whose pacity of the former after extensive iodination. physical and chemical properties are not grossly Since both iron and transferrin levels are af- altered, the possible effects of iodination on the fected in a variety of disease states, a technique functional properties of such substances in a in which both can be followed simultaneously in physiologic setting have been less thoroughly in- vivo should prove valuable. Elmlinger and co- vestigated. That it is possible to trace label pro- workers (18) have reported in abstract form on teins without significantly reducing their biologi- the use of doubly labeled "iron-binding globulin" cal activities has been demonstrated in the case of in human subjects, but few details were given as insulin (2) and certain anterior pituitary hor- to the methods of preparation and the distribution mones (3, 4). of the two labels.
    [Show full text]
  • Sites of Formation of the Serum Proteins Transferrin and Hemopexin
    Sites of Formation of the Serum Proteins Transferrin and Hemopexin G. J. Thorbecke, … , K. Cox, U. Muller-Eberhard J Clin Invest. 1973;52(3):725-731. https://doi.org/10.1172/JCI107234. Research Article Sites of synthesis of hemopexin and transferrin were determined by culturing various tissues of rabbits and monkeys in the presence of labeled amino acids. Labeling of the serum proteins was examined by means of autoradiographs of immunoelectrophoretic patterns as well as by precipitation in the test tubes employing immunospecific antisera. Good correlation was seen between the results obtained by the two different methods. The liver was found to be the only site of many tissues studied that synthesized hemopexin. Transferrin production was observed in the liver, submaxillary gland, lactating mammary gland, testis, and ovary. Find the latest version: https://jci.me/107234/pdf Sites of Formation of the Serum Proteins Transferrin and Hemopexin G. J. THORBECKE, H. H. LiEM, S. KNIGHT, K. Cox, and U. MULLER-EBERHARD From the Department of Pathology, New York University School of Medicine, New York 10016, and the Department of Biochemistry, Scripps Clinic and Research Foundation, and Division of Pediatric Hematology, University of California at San Diego, La Jolla, California 92037 A B S T R A C T Sites of synthesis of hemopexin and in iron deficiency and the decrease in inflammatory re- transferrin were determined by culturing various tis- actions (8). sues of rabbits and monkeys in the presence of labeled Preliminary findings (9, 10) suggested that hemo- amino acids. Labeling of the serum proteins was ex- pexin is formed by the liver.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,940,687 B2 Naidu Et Al
    USOO8940687B2 (12) United States Patent (10) Patent No.: US 8,940,687 B2 Naidu et al. (45) Date of Patent: Jan. 27, 2015 (54) ANTIMICROBIAL ANGIOGENIN 5,286,487 A 2/1994 Vallee et al. COMPLEXES (ANGEX) AND USES THEREOF 7,074,7596,172,040 B2B1 7,1/2001 2006 Naidu 7,125,963 B2 10/2006 Naidu (71) Applicant: Naidu LP, Pomona, CA (US) 7,601,689 B2 10/2009 Naidu 7.956,031 B2 6, 2011 Naidu et al. (72) Inventors: A. Satyanarayan Naidu, Diamond Bar, 8,003,603 B2 8/2011 Naidu CA (US); A. G. Tezus Naidu, Santa 8,021,659 B2 9, 2011 Naidu et al. Ana, CA (US); A. G. Sreus Naidu, 8,309,080 B2 11/2012 Naidu et al. Santa Ana, CA (US 2007, 0141101 A1 6/2007 Nugent et al. anta Ana, CA (US) 2008/02540.18 A1 10, 2008 Naidu 2011/0200575 A1 8, 2011 Naidu et al. (73) Assignee: Naidu LP, Pomona, CA (US) 2011/0286986 A1 11/2011 Naidu et al. (*) Notice: Subject to any disclaimer, the term of this OTHER PUBLICATIONS patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days. González-Chávez et al. ((International Journal of Antimicrobial 21) Appl. No.: 13/861,236 Agents 33 (2009) 301.e1-301.e8).* (21) ppl. No.: 9 Acharya, et al. “Crystal Structure of Human Angiogenin Reveals the Structural Basis for its Functional Divergence from Ribonuclease.” (22) Filed: Apr. 11, 2013 Proc. Natl. Acad. Sci. USA, vol. 91, pp. 2915-2919, Apr. 1994. O O Hu, et al.
    [Show full text]
  • Sourcebook in Forensic Serology, Immunology, and Biochemistry
    UNIT VII. HEMOGLOBIN, SERUM GROUP SYSTEMS, HLA AND OTHER GENETIC MARKERS Hemoglobin SECTION 38. HEMOGLOBIN 38.1 Introduction Hemoglobin (Hb)is the major protein of human red cells, forth. Hemoglobins exist which contain only one kind of comprising about 95% of their dry weight. Adult human chain: Hb H is B4, for example, and Hb Bart's is 7,. blood normally contains from about 4 million to 6.5 million Jones (1961) pointed out that hemoglobin structural red cells per mm3 blood, the average figure being slightly heterogeneity can be classified as follows: (1) Maturation higher for men. Hemoglobin itself is present in concentra- heterogeneity, which refers to the fact that different tions of about 14 to 16 g per 100 mP blood. It is the oxygen hemoglobins are normally synthesized during different transporting protein in higher animals; without a molecule stages of development. There are embryonic, fetal and adult having its properties, complex multicellular aerobic life as hemoglobins. (2) Minor hemoglobin heterogeneity, which we know it would not be possible. refers to the presence of small amounts of structurally dif- Hemoglobin is one of the most extensively studied of all ferent but normal hemoglobins along with the major proteins, and its literature fills many volumes. As noted in component characteristic of a particular stage of develop- section 5.1, it acquired its present name over 100 years ago ment; and (3) genetic heterogeneity, which refers to the (Hoppe-Seyler, 1864). In forensic serology, hemoglobiin is various "abnormal" hemoglobin variants. Many of these important in two principal contexts: (1) Blood is normally are thought to be the result of point mutations, and with a idenad in questioned samples by procedures designed to few exceptions, variant hemoglobins are very rare.
    [Show full text]
  • The Nutraceutical Properties of Ovotransferrin and Its Potential Utilization As a Functional Food
    Review The Nutraceutical Properties of Ovotransferrin and Its Potential Utilization as a Functional Food Francesco Giansanti 1,2,*, Loris Leboffe 2,3, Francesco Angelucci 1 and Giovanni Antonini 2,3 Received: 29 September 2015 ; Accepted: 23 October 2015 ; Published: 4 November 2015 1 Department of Health, Life and Environmental Sciences, University of L’Aquila, L’Aquila I-67100, Italy; [email protected] 2 Interuniversity Consortium INBB Biostructures and Biosystems National Institute, Rome I-00136, Italy; [email protected] (L.L.); [email protected] (G.A.) 3 Department of Sciences, Roma Tre University, Rome I-00146, Italy * Correspondence: [email protected]; Tel.: +39-0862-433245; Fax: +39-0862-433273 Abstract: Ovotransferrin or conalbumin belong to the transferrin protein family and is endowed with both iron-transfer and protective activities. In addition to its well-known antibacterial properties, ovotransferrin displays other protective roles similar to those already ascertained for the homologous mammalian lactoferrin. These additional functions, in many cases not directly related to iron binding, are also displayed by the peptides derived from partial hydrolysis of ovotransferrin, suggesting a direct relationship between egg consumption and human health. Keywords: ovotransferrin; nutraceutical; functional food; antioxidant 1. Introduction Ovotransferrin (Otrf) or conalbumin belongs to the family of transferrin iron-binding glycoproteins. In mammals, two different soluble iron-binding glycoproteins are present: (i) serum transferrin, involved in iron transport and delivery to cells and (ii) lactoferrin, involved in the so-called natural immunity. Differently, Otrf is the only soluble glycoprotein of the transferrin protein family present in avian. Otrf is present both in avian plasma and egg white and possesses both iron-transfer and protective properties [1].
    [Show full text]
  • VLA-4 Integrin Concentrates at the Peripheral Supramolecular Activation Complex of the Immune Synapse and Drives T Helper 1 Responses
    VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses Marı´aMittelbrunn*†, Ana Molina†‡, Marı´aM. Escribese‡, Marı´aYa´ n˜ ez-Mo´ *, Ester Escudero‡, Angeles´ Ursa*, Reyes Tejedor*, Francisco Mampaso‡, and Francisco Sa´ nchez-Madrid*§ *Servicio de Inmunologı´a,Hospital de la Princesa, Universidad Auto´noma de Madrid, Madrid 28006, Spain; and ‡Departamento de Patologı´a,Hospital Ramo´n y Cajal, Universidad de Alcala´, Madrid 28001, Spain Edited by Ralph M. Steinman, The Rockefeller University, New York, NY, and approved June 10, 2004 (received for review November 28, 2003) ␣ ␤ ␣ ␤ The integrin 4 1 (VLA-4) not only mediates the adhesion and whereas the involvement of L 2 during Ag presentation is well ␣ ␤ ␣ ␤ transendothelial migration of leukocytes, but also provides co- known, the role of 4 1 has not been addressed. The L 2 stimulatory signals that contribute to the activation of T lympho- integrin mediates T cell adhesion to APCs, facilitating the cytes. However, the behavior of ␣4␤1 during the formation of the formation of the immunological synapse (IS) (6). The pair ␣ ␤ ␣ ␤ ͞ immune synapse is currently unknown. Here, we show that 4 1 L 2 intracellular adhesion molecule-1 (ICAM-1) forms an is recruited to both human and murine antigen-dependent immune adhesion ring that is called the peripheral supramolecular acti- synapses, when the antigen-presenting cell is a B lymphocyte or a vation complex (pSMAC), that surrounds the T cell receptor– dendritic cell, colocalizing with LFA-1 at the peripheral supramo- peptide–MHC complexes localized at the central SMAC of the ␣ ␤ ͞ lecular activation complex.
    [Show full text]
  • A Review on Ovalbumin Gene in Poultry
    Journal of Entomology and Zoology Studies 2018; 6(4): 1497-1503 E-ISSN: 2320-7078 P-ISSN: 2349-6800 A review on ovalbumin gene in poultry JEZS 2018; 6(4): 1497-1503 © 2018 JEZS Received: 04-05-2018 Accepted: 05-06-2018 Kanaka KK, Jeevan C, Chethan Raj R, NG Sagar, Rajendra Prasad, C Kotresh Prasad and Shruthi S Kanaka KK Indian Veterinary Research Institute, Izatnagar, Abstract Utter Pradesh, India Ovalbumin is a major protein in the egg white. It is a monomeric phosphor glycoprotein with a known complete amino acid sequence of 386 residues. Due to its structural similarities with the serine protease Jeevan C inhibitors (Ser PIns), it is included in the serpin super family, although it lacks inhibitory activities. The National Dairy Research size of the entire ovalbumin gene in poultry is approximately 7.6 kb of DNA with 7 exons and 6 introns, Institute, Karnal, Haryana, in order to code for mRNA of 1859 nucleotides. Tubular gland cells of magnum are responsible for the India production of ovalbumin protein. Ovalbumin gene in poultry have been found polymorphic in various Chethan Raj R populations in various parts of gene including coding sequence, promoter region etc., ovalbumin serve as Indian Veterinary Research a source of amino acid and may also have a more active/direct function on developing tissues and Institute, Izatnagar, believed to play a crucial role in bio mineralization. Utter Pradesh, India Keywords: Ovalbumin, characterization, expression, polymorphism NG Sagar Indian Veterinary Research Introduction Institute, Izatnagar, Ovalbumin, a SERPIN family protein is the major protein in the egg white.
    [Show full text]
  • For Reference Only
    Product Manual Revision date: 24/Apr/2019 Chicken Ovotransferrin (Conalbumin) ELISA Kit Catalog No.: abx356943 Size: 96T Range: 31.2 pg/ml - 2000 pg/ml Sensitivity: 18.8 pg/ml Storage: Store the 96-well plate, Standards, HRP-conjugate reagent and Biotin-conjugated antibody at -20°C, and the rest of the kit components at 4°C for up to 6 months. Application: For quantitative detection of Conalbumin in Chicken Serum, Plasma and other biological fluids. Introduction: Ovotransferrin (conalbumin) is a glycoprotein of egg white albumen. Egg white albumen is composed of multiple proteins, of which ovotransferrin is the most heat reliable. It has a molecular weight of 76,000 daltons and contains about 700 amino acids. Ovotransferrin makes up approximately 13% of egg albumen (in contrast to ovalbumin, which comprises 54%). As a member of the transferrin and metalloproteinase family, ovotransferrin has been found to produce heat shock proteins. When these heat shock proteins are induced in the skin, they provide protection against cold stress and other environmental stresses. Principle of the Assay This kit is based on sandwich enzyme-linked immuno-sorbent assay technology. An antibody specific to Conalbumin is pre-coated onto a 96-well plate. The standards and samples are added to the wells, incubated and washed with wash buffer. A biotin conjugated antibody specific to Conalbumin is used for detection. TMB substrate is used to visualize HRP activity. TMB is catalyzed by HRP to produce a blue colour product that changes into yellow after adding stop solution. The intensity of the color yellow is proportional to the Conalbumin amount bound on the plate.
    [Show full text]
  • Rabbit Anti Ovotransferrin Polyclonal Antibody Application: ELISA, WB Alternate Names: Ovotransferrin (Otf); LTF; Conalbumin, TF; TFEW Reactivity: Chicken
    Order Information Description: Rabbit anti-Ovotransferrin Catalogue#: 601-760 Lot#: See the label Size: 100 ug/200 ul Host: Rabbit Clone: N/A Rabbit anti Ovotransferrin Polyclonal Antibody Application: ELISA, WB Alternate Names: Ovotransferrin (OTf); LTF; Conalbumin, TF; TFEW Reactivity: Chicken ANTIGEN PREPARATION A synthetic peptide close to C-terminus of chicken egg white Ovotransferrin protein. BACKGROUND Ovotransferrin is a 705 aa, monomeric, glycosylated, 80 kDa protein isolated from chicken egg white. It is involved in response to oxidative stress in embryogenesis to maintain a steady reducing environment (known as confer protection). Ovotransferrin is the second major protein in egg albumin, undergoes autocleavage at distinct sites upon reduction with thiol- reducing system. The major proteins of chicken eggs are: Ovalbumin (45 kda, 54%), Conalbumin/Ovotransferrin (13%, 80 kda), Ovomucoid (11%, 28 kda), Lysozyme (3.5%, 14 kda), and other proteins. PURIFICATION FORMULATION This affinity purified antibody is supplied in sterile phosphate- The Rabbit IgG is purified by Epitope Affinity Purification. buffered saline (pH7.2) containing antibody stabilizer SPECIFICITY STORAGE The antibodies are stable for 12 months from date of receipt when This antibody recognizes ~80 kDa of chicken egg white stored at –20 oC to –70 oC. The antibodies can be stored at 2 oC-8oC Ovotransferrin. for three month without detectable loss of activity. Avoid repeated freezing-thawing cycles. APPLICATIONS/SUGGESTED WORKING DILUTIONS Western Blot 0.1-1 µg/ml MOLECULAR WEIGHT: ~80 kDa ELISA 0.01-0.1 µg/ml POSITIVE CONTROL: Ovotransferrin Immunoprecipitation N/A CELLULAR LOCATION: N/A IHC N/A Optimal dilutions should be determined by researchers for the Flow cytometry N/A specific applications.
    [Show full text]